SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

Author:

Pajon Rolando1,Doria-Rose Nicole A.2ORCID,Shen Xiaoying3,Schmidt Stephen D.,O’Dell Sijy,McDanal Charlene,Feng Wenhong,Tong Jin,Eaton Amanda,Maglinao Maha1,Tang Haili3,Manning Kelly E.,Edara Venkata-Viswanadh,Lai Lilin,Ellis MadisonORCID,Moore Kathryn M.,Floyd Katharine,Foster Stephanie L.,Posavad Christine M.4,Atmar Robert L.5,Lyke Kirsten E.6,Zhou TongqingORCID,Wang Lingshu,Zhang Yi,Gaudinski Martin R.ORCID,Black Walker P.,Gordon Ingelise,Guech Mercy,Ledgerwood Julie E.,Misasi John N.,Widge AliciaORCID,Sullivan Nancy J.,Roberts Paul C.,Beigel John H.ORCID,Korber Bette7,Baden Lindsey R.8,El Sahly Hana5ORCID,Chalkias Spyros,Zhou Honghong,Feng Jing,Girard Bethany,Das Rituparna,Aunins Anne,Edwards Darin K.,Suthar Mehul S.9ORCID,Mascola John R.10,Montefiori David C.3

Affiliation:

1. Moderna, Cambridge, MA

2. National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD

3. Duke University Medical Center, Durham, NC

4. Fred Hutchinson Cancer Research Center, Seattle, WA

5. Baylor College of Medicine, Houston, TX

6. University of Maryland School of Medicine, Baltimore, MD

7. Los Alamos National Laboratory, Los Alamos, NM

8. Brigham and Women’s Hospital, Boston, MA

9. Emory University School of Medicine, Atlanta, GA

10. NIAID, Bethesda, MD

Funder

Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority

HIV Vaccine Trials Network (HVTN) Leadership and Operations Center

NIAID to Statistics and Data Management Center

NIAID to the HVTN Laboratory Center

NIAID to the Prevention Trials Network Leadership and Operations Center

NIAID to AIDS Clinical Trials Group Leadership and Operations Center

NIAID to Infectious Diseases Clinical Research Consortium leadership group 5

National Institutes of Health

Intramural Research Program of the Vaccine Research Center, NIAID, NIH

Moderna, Inc.

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3